CRY1 has been implicated as a prognostic marker progression and survival in CLL and other types of cancer, however, the role of URAHP, MID1IP1, and CLEC3B has not been explored in CLL [58, 59]. The gene discussed is CRY1; the disease is B-cell chronic lymphocytic leukemia.